{
 "drug": "Sodium Chloride 0.9% Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "12/03/2025",
 "dayN": 265,
 "cat": "Gastroenterology",
 "companies": [
  "Hospira, Inc., a Pfizer Company"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "12/03/2025",
   "update_type": "New",
   "initial_posting_date": "12/03/2025",
   "package_ndc": "0409-7101-67",
   "generic_name": "Sodium Chloride 0.9% Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA019465"
    ],
    "brand_name": [
     "SODIUM CHLORIDE"
    ],
    "generic_name": [
     "SODIUM CHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-7101",
     "0409-7132"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM CHLORIDE"
    ],
    "rxcui": [
     "1807547",
     "1807631",
     "1807632",
     "1807633"
    ],
    "spl_id": [
     "147cbba6-2ead-49c4-bce7-4e9c65b303c9"
    ],
    "spl_set_id": [
     "a2a964f7-c3ec-4dfb-e3a0-6d8136a80397"
    ],
    "package_ndc": [
     "0409-7101-68",
     "0409-7101-66",
     "0409-7101-69",
     "0409-7101-67",
     "0409-7101-04",
     "0409-7101-02",
     "0409-7132-68",
     "0409-7132-66",
     "0409-7132-69",
     "0409-7132-67",
     "0409-7132-04",
     "0409-7132-02"
    ],
    "unii": [
     "451W47IQ8X"
    ]
   },
   "update_date": "12/03/2025",
   "therapeutic_category": [
    "Gastroenterology",
    "Other",
    "Renal"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Chloride 0.9%, Injection, 100 mL  ADD-Vantage® Flexible Container (NDC 0409-7101-67)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "12/03/2025",
   "update_type": "New",
   "initial_posting_date": "12/03/2025",
   "package_ndc": "0409-7101-66",
   "generic_name": "Sodium Chloride 0.9% Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA019465"
    ],
    "brand_name": [
     "SODIUM CHLORIDE"
    ],
    "generic_name": [
     "SODIUM CHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-7101",
     "0409-7132"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM CHLORIDE"
    ],
    "rxcui": [
     "1807547",
     "1807631",
     "1807632",
     "1807633"
    ],
    "spl_id": [
     "147cbba6-2ead-49c4-bce7-4e9c65b303c9"
    ],
    "spl_set_id": [
     "a2a964f7-c3ec-4dfb-e3a0-6d8136a80397"
    ],
    "package_ndc": [
     "0409-7101-68",
     "0409-7101-66",
     "0409-7101-69",
     "0409-7101-67",
     "0409-7101-04",
     "0409-7101-02",
     "0409-7132-68",
     "0409-7132-66",
     "0409-7132-69",
     "0409-7132-67",
     "0409-7132-04",
     "0409-7132-02"
    ],
    "unii": [
     "451W47IQ8X"
    ]
   },
   "update_date": "12/03/2025",
   "therapeutic_category": [
    "Gastroenterology",
    "Other",
    "Renal"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Chloride 0.9%, Injection, 50 mL  ADD-Vantage® Flexible Container (NDC 0409-7101-66)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "12/03/2025",
   "update_type": "New",
   "initial_posting_date": "12/03/2025",
   "package_ndc": "0409-7101-02",
   "generic_name": "Sodium Chloride 0.9% Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA019465"
    ],
    "brand_name": [
     "SODIUM CHLORIDE"
    ],
    "generic_name": [
     "SODIUM CHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-7101",
     "0409-7132"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM CHLORIDE"
    ],
    "rxcui": [
     "1807547",
     "1807631",
     "1807632",
     "1807633"
    ],
    "spl_id": [
     "147cbba6-2ead-49c4-bce7-4e9c65b303c9"
    ],
    "spl_set_id": [
     "a2a964f7-c3ec-4dfb-e3a0-6d8136a80397"
    ],
    "package_ndc": [
     "0409-7101-68",
     "0409-7101-66",
     "0409-7101-69",
     "0409-7101-67",
     "0409-7101-04",
     "0409-7101-02",
     "0409-7132-68",
     "0409-7132-66",
     "0409-7132-69",
     "0409-7132-67",
     "0409-7132-04",
     "0409-7132-02"
    ],
    "unii": [
     "451W47IQ8X"
    ]
   },
   "update_date": "12/03/2025",
   "therapeutic_category": [
    "Gastroenterology",
    "Other",
    "Renal"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Chloride 0.9%, Injection, 250 mL  ADD-Vantage® Flexible Container (NDC 0409-7101-02)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  }
 ]
}